Navigation Links
Novo Nordisk Creates First Mobile Application to Help Doctors Diagnose Bleeding Disorders

PRINCETON, N.J., Feb. 4, 2011 /PRNewswire/ -- Novo Nordisk announced today the availability of Coags Uncomplicated – the first mobile application (app) to assist in the diagnosis of bleeding disorders – created in partnership with Craig Kessler, MD, Professor of Medicine and Pathology and Director of the Coagulation Laboratory, Georgetown University Hospital, Lombardi Comprehensive Cancer Center. Coags Uncomplicated features a Lab Value Analyzer that enables physicians to input test results and receive a list of potential diagnoses to consider including a description of each bleeding disorder and typical lab values.  The app also provides step-by-step suggestions for appropriate lab tests to narrow possible diagnoses.

With the potential to help clinicians quickly and more accurately diagnose bleeding disorders, the app provides for the first time, in one place, information about bleeding disorders and their effects on coagulation laboratory tests.

"While physicians are increasingly using hand-held devices to access medical information, no such tool has existed to help with the diagnosis of bleeding disorders, especially when getting to the correct diagnosis quickly may be critical," said Eddie Williams, Vice President, Biopharmaceuticals.  "Novo Nordisk was pleased to collaborate with Dr. Kessler on this innovative approach to addressing an unmet need, further demonstrating our commitment to the bleeding disorder community."

The basis for the app came from U.S. market research results, which identified a gap in many specialists' recognition of abnormal blood clotting activity in a bleeding patient; often resulting in a focus on the location of the bleed rather than the cause.  These findings were presented at the 2010 American Society of Hematology (ASH) Annual Meeting.

The Coags Uncomplicated app is available for free download at  For individuals who do not have an iPhone, the app tools and additional information can also be accessed online.

About Novo Nordisk

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. Headquartered in Denmark, Novo Nordisk employs more than 29,650 employees in 76 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchange in Copenhagen and its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit

iPhone and iTunes are registered trademarks of Apple Inc.

SOURCE Novo Nordisk
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
2. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
3. Novo Nordisk Wins Design Award for NovoTwist(TM) Needle
4. Novo Nordisk is Changing Possibilities in Hemophilia
5. Novo Nordisks Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
6. Novo Nordisk Awarded Department of Veterans Affairs National Insulin Contract
7. Novo Nordisk partners with international scientific community for Victoza(R) cardiovascular outcomes trial
8. Novo Nordisk Awards More Than $300,000 in Grants to Support Education and Community Health Programs
9. Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp
10. Novo Nordisk Addresses Innovation in Diabetes Care in Second Issue of Industry Resource for Information on Diabetes and Chronic Disease
11. Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 3D ... by 2022, according to a new report by Grand View ... Kidney Disease (CKD) which demands kidney transplantation is expected to ... cost effective substitute for organ transplantation. --> 3D ... by 2022, according to a new report by Grand View ...
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in ... Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new ... Italian therapeutic drug monitoring market, including emerging tests, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 25, 2015 , ... Wimbledon Health Partners, the industry leader ... Athletics Facebook page to educate the public, parents and school athletic departments ... people under the age of 25 die from sudden cardiac arrest every year. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is pleased ... moderate facial wrinkling. While many patients are aware of the benefits of Botox® in ... delivers to those suffering with discomfort, soreness, and pain as a result of Jaw ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, ... friendships, and learning in its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, ... , For 65 years, Brillianteen has been a treasured tradition for numerous families ...
(Date:11/25/2015)... ... 2015 , ... Today, Mothers Against Drunk Driving (MADD) learned that ... for the first time since 2011. In 2014, there were 9,967 fatalities involving an ... the National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in traffic crashes ...
(Date:11/25/2015)... ... November 25, 2015 , ... "When I underwent ... bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order to ... the patent-pending RECOVERY BRA for added comfort and support. The bra is easier ...
Breaking Medicine News(10 mins):